Home > Gleevec > Nephrolithiasis > Gleevec and Nephrolithiasis
Review: could Gleevec cause Nephrolithiasis (Kidney stones)?
We study 20,252 people who have side effects while taking Gleevec from FDA and social media. Among them, 84 have Nephrolithiasis. Find out below who they are, when they have Nephrolithiasis and more.
Gleevec (latest outcomes from 20,436 users) has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml).
Nephrolithiasis (calculi in the kidneys) (latest reports from 106,272 patients) has been reported by people with multiple sclerosis, osteoporosis, high blood pressure, rheumatoid arthritis, pain.
On Sep, 19, 2014: 20,252 people reported to have side effects when taking Gleevec. Among them, 84 people (0.41%) have Nephrolithiasis.
Time on Gleevec when people have Nephrolithiasis * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
Gender of people who have Nephrolithiasis when taking Gleevec * :
Age of people who have Nephrolithiasis when taking Gleevec * :
Severity of Nephrolithiasis when taking Gleevec ** :
How people recovered from Nephrolithiasis ** :
Top conditions involved for these people * :
- Prophylaxis (35 people, 41.67%)
- Chronic myeloid leukaemia (33 people, 39.29%)
- Gastrointestinal stromal tumour (10 people, 11.90%)
- Osteoporosis (10 people, 11.90%)
- Malignant soft tissue neoplasm (9 people, 10.71%)
Top co-used drugs for these people * :
- Methotrexate (35 people, 41.67%)
- Zantac (35 people, 41.67%)
- Mercaptopurine (35 people, 41.67%)
- Bactrim (35 people, 41.67%)
- Cyclophosphamide (35 people, 41.67%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Nephrolithiasis while taking Gleevec?
Get connected! Join a mobile support group:
- group for people who take Gleevec and have Nephrolithiasis
- group for people who take Gleevec
- group for people who have Nephrolithiasis
Comments from related studies:
From this study (1 month ago):
I was just wondering if taking gleevec for 3 years would cause hearing loss (ringing in the ear)
From this study (2 months ago):
I was prescribed Imatinib for 3 years after GIST was removed, to try prevent recurrence, Over 2 years into course, developed severe cough and cold which have persisted, more or less, to this day. Was hospitalised early this year to get rid of gunge in my lungs and afterwards (March) had a bronchoscopy. Within hours my right ear had blocked and so it has remained. 3 weeks ago had grommet fitted but that hasn't worked - it became 'crusted over' and the crust has apparently been removed but it will almost certainly (in my view) happen again - because I still have this horrible gunge in my nose and it sets like concrete, which is presumably what happened in my ear.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Gleevec, Nephrolithiasis
More reviews for: Gleevec, Nephrolithiasis
On eHealthMe, Gleevec (imatinib mesylate) is often used for chronic myelogenous leukemia (cml). Find out below the conditions Gleevec is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Gleevec used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Nephrolithiasis is also known as: Kidney stones, Renal calculi, Stones - kidney.
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.